RESTI NURFALAH, - (2022) PROFIL KEBERHASILAN TERAPI OBAT BRONKOPNEUMONIA PADA BALITA DI INSTALASI RAWAT INAP RUMAH SAKIT UMUM DAERAH SOREANG PERIODE BULAN SEPTEMBER-DESEMBER 2021. Skripsi thesis, Sekolah Tinggi Farmasi Indonesia.
![[img]](http://repository.stfi.ac.id/style/images/fileicons/text.png) |
Text
S_PSSF_A182026_Title.pdf Download (346kB) |
|
Text
S_PSSF_A182026_Chapter1.pdf Restricted to Repository staff only Download (100kB) |
|
Text
S_PSSF_A182026_Chapter2.pdf Restricted to Repository staff only Download (291kB) |
|
Text
S_PSSF_A182026_Chapter3.pdf Restricted to Repository staff only Download (37kB) |
|
Text
S_PSSF_A182026_Chapter4.pdf Restricted to Repository staff only Download (127kB) |
|
Text
S_PSSF_A182026_Chapter5.pdf Restricted to Repository staff only Download (28kB) |
|
Text
S_PSSF_A182026_Appendix.pdf Restricted to Repository staff only Download (1MB) |
Abstract
Bronkopneumonia merupakan penyakit infeksi yang sangat sering ditemukan dan menyebabkan jumlah kematian yang tinggi pada balita di negara berkembang khususnya di Indonesia. Oleh karena itu penelitian ini dilakukan untuk mengetahui keberhasilan terapi obat untuk pasien bronkopneumonia balita di instalasi rawat inap Rumah Sakit Umum Daerah Soreang periode SeptemberDesember 2021. Penelitian ini merupakan penelitian deskriptif. Subjek penelitian adalah pasien balita di instalasi rawat inap Rumah Sakit Umum Daerah Soreang dengan diagnosa utama bronkopneumonia dan memenuhi kriteria inklusi. Dari 44 sampel yang didapatkan, terapi obat yang diberikan antara lain antibiotik golongan cefalosporin dan aminoglikosida serta obat suportif seperti paracetamol, ambroxol, dexamethason, metil predisolon, dan combivent nebu. Dan dapat disimpulkan bahwa keberhasilan terapi obat bronkopneumonia pada balita di Instalasi Rawat Inap Rumah Sakit Umum Daerah Soreang periode SeptemberDesember 2021 mencapai 89% pasien sembuh dan 11% pasien perbaikan. --- Bronchopneumonia is an infectious disease which is very often found and causes a high number of deaths in children under five in developing countries, especially in Indonesia. Therefore, this study was conducted to determine the success of drug therapy for bronchopneumonia patients under five in the inpatient installation of the Soreang Regional General Hospital (RSUD Soreang) during the period of September to December 2021. This study is a descriptive study. The research subjects were under-five patients in the inpatient installation of the Soreang Regional General Hospital (RSUD Soreang) with the main diagnosis of bronchopneumonia and meeting the inclusion criteria. Of the 44 samples obtained, the drug therapy given included cephalosporin and aminoglycoside antibiotics as well as supportive drugs such as paracetamol, ambroxol, dexamethason, methyl predisolone, and combivent nebu. And it can be concluded that the success of bronchopneumonia drug therapy in toddlers at the Inpatient Installation of the Soreang Regional General Hospital (RSUD Soreang) during the period of September to December 2021 reached 89% of patients recovered wwwwwand 11% of patients improved.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Uncontrolled Keywords: | Pneumonia, Bronkopneumonia, Balita, Obat. --- Pneumonia, Bronchopneumonia, Toddlers, Drug. |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine |
| Divisions: | Program Studi S1 Farmasi |
| Depositing User: | pustakawan - - |
| Date Deposited: | 14 Sep 2024 13:46 |
| Last Modified: | 14 Sep 2024 13:46 |
| URI: | http://repository.stfi.ac.id/id/eprint/1211 |
Actions (login required)
 |
View Item |
